Concord Healthcare Group Co., Ltd. Class H

As of December 31, 2024, Concord Healthcare Group Co., Ltd. Class H carries a market capitalization of 7.88B, placing it among publicly traded companies globally. Its enterprise value stands at 11.21B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2024, Concord Healthcare Group Co., Ltd. Class H has 716.34M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Concord Healthcare Group Co., Ltd. Class H maintains a current ratio of 0.63, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 22, 2026, Concord Healthcare Group Co., Ltd. Class H's stock has declined approximately 76.96% over the past 52 weeks. The 50-day moving average sits at 0.76, while the 200-day moving average is 1.14.

As of December 31, 2024, Concord Healthcare Group Co., Ltd. Class H holds 358.77M in cash and equivalents against 3.42B in total debt, resulting in a net debt position of 3.08B. Total book value stands at 1.75B, with working capital of -449.36M providing operational flexibility.